Matthew Goff Investment Advisor’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
IWS
MCM
AWM
FP
MFG
AFG
DADC
HCMT
SIA
Matthew Goff Investment Advisor's IHE Position: Q2 2026 in Review
Matthew Goff Investment Advisor held its iShares US Pharmaceuticals ETF (IHE) position steady in Q2 2026 at 3,615 shares worth $358K. The position accounts for 0.06% of the portfolio, ranked #82.
Matthew Goff Investment Advisor first reported a position in IHE in Q2 2018 and has held it in 24 quarters since. The position peaked at $678K in Q2 2018. 50 funds tracked by Wall St. Rank hold IHE as of Q2 2026.
- Matthew Goff Investment Advisor held 3,615 shares of iShares US Pharmaceuticals ETF worth $358K as of Q2 2026.
- Matthew Goff Investment Advisor left its iShares US Pharmaceuticals ETF share count unchanged in Q2 2026.
- iShares US Pharmaceuticals ETF made up 0.06% of Matthew Goff Investment Advisor's portfolio in Q2 2026, its #82 holding.
- Matthew Goff Investment Advisor first reported a position in iShares US Pharmaceuticals ETF in Q2 2018 and has held it in 24 quarters since.
- Matthew Goff Investment Advisor's iShares US Pharmaceuticals ETF position peaked at $678K in Q2 2018.
- 50 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.
Based on Matthew Goff Investment Advisor's 13F filing for Q2 2026, filed 8 Jul 2026.